Evidence map›Paper›PMID 31163612›Full record

ArticleSensors (Basel, Switzerland)2019

Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody.

Dorin Harpaz, Brescia Koh, Robert S Marks, Raymond C S Seet, Ibrahim Abdulhalim, Alfred I Y Tok

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Review
  3. Clinical Markers and Diagnostics for Diagnosing Cerebral Infarction.CNS & neurological disorders drug targets · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Biosensors Based on Inorganic Composite Fluorescent Hydrogels.Nanomaterials (Basel, Switzerland) · 2023
    Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Dorin HarpazSchool of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore. DORIN001@e.ntu.edu.sg.ORCID 0000-0003-4119-6284
Brescia KohSchool of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore. rkoh009@e.ntu.edu.sg.
Robert S MarksDepartment of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel. rsmarks@bgu.ac.il.
Raymond C S SeetDivision of Neurology, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Dr, Singapore 117597, Singapore. mdcrscs@nus.edu.sg.
Ibrahim AbdulhalimSchool of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore. abdulhlm@bgu.ac.il.ORCID 0000-0002-1474-5412
Alfred I Y TokSchool of Material Science & Engineering, Nanyang Technology University, 50 Nanyang Avenue, Singapore 639798, Singapore. MIYTok@ntu.edu.sg.ORCID 0000-0003-3546-7180
Ben-Gurion University of the Negev · ILNanyang Technological University · SGNational University of Singapore · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface-plasmon-resonance (SPR) is a quantum-electromagnetic phenomenon arising from the interaction of light with free electrons at a metal-dielectric interface. At a specific angle/wavelength of light, the photon's energy is transferred to excite the oscillation of the free electrons on the surface. A change in the refractive-index (RI) may occur, which is influenced by the analyte concentration in the medium in close contact with the metal surface. SPR has been widely used for the detection of gaseous, liquid, or solid samples. In this study, a functionalized specific SPR chip was designed and used in a novel point-of-care SPR module (PhotonicSys SPR H5) for the detection of the stroke biomarkers NT-proBNP and S100β. These biomarkers have proven to be good for stroke diagnosis, with sensitivity and specificity of >85%. Specific detection was done by binding a biomolecular-recognizing antibody onto the Au SPR-chip. Detection was tested in water and plasma samples. NT-proBNP and S100β were detected in a range of concentrations for stroke, from 0.1 ng/mL to 10 ng/mL. The RI of the blank plasma samples was 1.362412, and the lowest concentration tested for both biomarkers showed a prominent shift in the RI signal (0.25 ng/mL NT-proBNP (1.364215) and S100β (1.364024)). The sensor demonstrated a clinically relevant limit-of-detection of less than ng/mL.

Indexed as

Biosensing TechniquesAntibodiesBiomarkersGoldHumansNatriuretic Peptide, BrainPeptide FragmentsPoint-of-Care SystemsS100 Calcium Binding Protein beta SubunitStrokeSurface Plasmon ResonanceAntibodiesBiomarkersGoldNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)S100B protein, humanS100 Calcium Binding Protein beta SubunitAu SPR-chipbiomarkersbiosensordiagnosticsNT-proBNPpoint-of-carerefractive-indexS100βstrokesurface-plasmon-resonance

Identifiers

PMID31163612
PMCPMC6603756
OpenAlexW2947404439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.